Medical marijuana advocates will get their day in court later this year, when they argue the therapeutic value of cannabis.
The United States Court of Appeals for the D.C. Circuit agreed late last week to hear oral arguments in Americans for Safe Access v. Drug Enforcement Administration,
a case that could have major implications for the rescheduling of
marijuana out of Schedule I, a category that also includes heroin and
LSD. Schedule I drugs are described as substances that have
